—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Medline Inc. Class A Common Stock（MDLN）— 同类公司组

数据截至2026-10-12 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

Medline Inc. Class A Common Stock的Closelook综合评分为44/100，在同类公司组内排名第9位（共10家）——组内评分最高的是Halozyme Therapeutics Inc（74/100）。

名称综合动量质量估值信号距52周高点
MDLN Medline Inc. Class A Common Stock44193036——
FPH.AU Fisher & Paykel Healthcare Corporation Ltd61847027ok0%
ISRG Intuitive Surgical Inc58367621neutral29.8%
YPSN.SW Ypsomed Holding AG56696228info13.7%
TECN.SW Tecan Group AG48932752ok7.7%
MMED MiniMed Group, Inc. Common Stock46772126——
EL.PA EssilorLuxottica S. A.4494558bear53.7%
HALO Halozyme Therapeutics Inc74949448ok4.9%
DXCM DexCom Inc66858035bull9.2%
ONC BeiGene, Ltd.63766230info9%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-12

Quick answers

Medline Inc. Class A Common Stock在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：Fisher & Paykel Healthcare Corporation Ltd (FPH.AU)、Intuitive Surgical Inc (ISRG)、Ypsomed Holding AG (YPSN.SW)、Tecan Group AG (TECN.SW)、MiniMed Group, Inc. Common Stock (MMED)、EssilorLuxottica S. A. (EL.PA)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

MDLN相对同类公司的评分如何？

Medline Inc. Class A Common Stock的综合评分为44/100，组内排名第9位（共10家），截至2026-10-12；组内最高综合评分为Halozyme Therapeutics Inc（74/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.